We read with interest the study by Mohamed Hoesein et al 1 (see page 1530), in which they nicely proved that rate of lung function decline is maximum in male heavy smokers with mild or no airfl ow limitation as documented on spirometry. However, the criteria for categorizing all enrolled patients into COPD have not been specifi ed. In view of the lack of spirometric evidence of airway obstruction and reversibility, it is plausible that some of the subjects may actually be suffering from other airway diseases, notably asthma, which usually do not result in progressive lung function decline. Segregation of such patients by serially testing with spirometry any time during the course of 3 years could have increased the specifi city of the study. Moreover, COPD is also known to occur in nonsmokers, predisposed by other risk factors like air pollution, 2 genetic predisposition, 3 and so forth. Inclusion of nonsmokers might have given a better picture of the association between rate of decline in lung function and stage of COPD.
Contal O , Vignaux L , Combescure C , Pepin J-L , Jolliet P , Janssens J-P . Monitoring of noninvasive ventilation by built-in software of home bilevel ventilators: a bench study . 
Response

To the Editor:
We thank Drs Aggarwal and colleagues for their valuable questions about and remarks on our article in CHEST . 1 To start with, we would like to emphasize that the included subjects were heavy smokers drawn from the general population: Non-smokingrelated diseases would show a study prevalence equal to that in the population. Asthma would, therefore, be present in the same (low) population percentage in all the groups we formed. As mentioned in the "Materials and Methods" section, the three groups were based on the baseline prebronchodilator FEV 1 /FVC: either . 70%, Յ 70% and greater than the lower limit of normal, or less than or equal to the lower limit of normal. Because asthma was neither an inclusion nor an exclusion criterion, asthmatic subjects were fully randomized over the three groups formed. The effect on lung function decline was therefore negligible.
The aim of the current study was to relate baseline FEV 1 /FVC to lung function decline in heavy smokers. We agree that COPD is also known to occur in nonsmokers; nonetheless, the majority of COPD in the Western World is caused by tobacco smoke and only a small minority by other causes. The subjects in this study originated from the concise Utrecht and Groningen areas in The Netherlands, and the air pollution burdens for the included subjects are very comparable. No large contrasts in terms of heavily 
The subjects in this observational study were not subjected to treatment as a result of the study fi ndings. In addition, there is now evidence that neither bronchodilator nor steroid treatment signifi cantly infl uences the decline of lung function over time. 2 , 3 Our study included mostly heavy smokers with an FEV 1 /FVC . 70% and with mild COPD. It has been shown that the number of exacerbations is low in GOLD (Global Initiative for Chronic Obstructive Lung Disease) stage II, and so it is not surprising that in our cohort the probability of prior exacerbations is even lower. 4 An exacerbation effect on FEV 1 decline is, therefore, minute and undetectable.
Shifting the Focus of ICU Staffi ng Research to the Community
To the Editor:
In an issue of CHEST (May 2012), I read with great interest the article on 24-h intensivist staffi ng in teaching hospitals by Kerlin and Halpern 1 because it was published at the same time as a large retrospective study that did not reveal a mortality benefi t with night intensivist staffi ng at high-intensity ICUs. 2 Kerlin and Halpern 1 make strong arguments in support of prospective randomized trials on the topic of ICU staffi ng. As well, I recently questioned the need for 24-h intensivist coverage on the basis of my anecdotal experience in the community setting. 3 In the article, the authors focused on the risks and benefi ts of 24-h attending staff as these relate to medical education and the care of patients in an academic setting. They also briefl y discussed the potential for the unintended consequences of decreased staffi ng and compromising care at regional hospitals, widening existing chasms of care. I emphasize that this is not a theoretical problem-it is real and ever growing in the community, where the shortage of trained intensivists is already painfully felt. For this reason, this topic should be examined in earnest, as advocated by the authors, and the focus should shift to the community setting. I believe that there is a pressing need to explore the value of night intensivists to community ICUs, more so than studying that of a night ICU attending physician working with trainees vs trainees alone to academic ICUs.
Most community hospitals in my metropolitan region have shifted from a 12-or 16-h workday to 24-h coverage. As Kerlin and Halpern 1 mentioned, the benefi ts of this move seemingly have strong face validity and the support of observational studies. However, a signifi cant consequence of this shift is that a small regional pool of community intensivists is now spread thin to cover nights. This, in turn, has led to lean and fractured day coverage and exacerbated a provider tug-of-war between facilities where full-time equivalent (FTE) and moonlighting physicians recruited to fi ll voids created by night staffi ng at one facility leave voids at another. For example, we recently recruited an FTE physician from one facility, leaving that facility, which had recently transitioned to 24-h coverage, more short staffed. A nearby hospital just transitioned to 24-h staffi ng and recruited one of our moonlighter physicians, necessitating our FTE physicians to work more nights. These voids are challenging to fi ll given the ongoing shortage of trained intensivists and may offset the purported benefi ts of 24-h coverage.
Nonacademic ICUs account for more than one-half of the ICUs in the United States. 4 Despite this, most ICU staffi ng research to date has involved academic centers, leaving a paucity of evidence to guide community ICU staffi ng. Research on staffi ng in academia has focused on the question of whether 24-h attending physician coverage is necessary. This has little bearing on community ICUs because these typically are staffed with one intensivist, not a team of trainees led by an attending physician. The main question for community ICUs is whether the presence of a night intensivist is at all necessary if there is high-intensity staffi ng during the day. Alternatives to 24-h intensivist staffi ng include night intensivist phone coverage, remote video monitoring, physician extender coverage, expanded hospitalist coverage, or any combination of these. These alternatives need to be explored rigorously because the demand for trained intensivists continues to outstrip supply. If viable, these alternatives may help to alleviate the increasing staffi ng strain in the community.
